Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials

# Background More than six million people died due to COVID-19, and 10-15% of infected individuals suffer from post-covid syndrome. Corticosteroids are widely used in the management of severe COVID-19 and post-acute COVID-19 symptoms. This study synthesizes current evidence of the effectiveness of...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasra Badi, Mohamed Hammad, Abdelrahman G. Tawfik, Mona Muhe Eldeen Eshag, Mahmoud M. Elhady, Khaled Mohamed Ragab, Anas Zakarya Nourelden, Mohamed Hesham Gamal, Ahmed Hashem Fathallah
Format: Article
Language:English
Published: Canadian Society of Respiratory Therapists 2023-08-01
Series:Canadian Journal of Respiratory Therapy
Online Access:https://doi.org/10.29390/001c.84260
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857505263943680
author Yasra Badi
Mohamed Hammad
Abdelrahman G. Tawfik
Mona Muhe Eldeen Eshag
Mahmoud M. Elhady
Khaled Mohamed Ragab
Anas Zakarya Nourelden
Mohamed Hesham Gamal
Ahmed Hashem Fathallah
author_facet Yasra Badi
Mohamed Hammad
Abdelrahman G. Tawfik
Mona Muhe Eldeen Eshag
Mahmoud M. Elhady
Khaled Mohamed Ragab
Anas Zakarya Nourelden
Mohamed Hesham Gamal
Ahmed Hashem Fathallah
author_sort Yasra Badi
collection DOAJ
description # Background More than six million people died due to COVID-19, and 10-15% of infected individuals suffer from post-covid syndrome. Corticosteroids are widely used in the management of severe COVID-19 and post-acute COVID-19 symptoms. This study synthesizes current evidence of the effectiveness of inhaled corticosteroids (ICS) on mortality, hospital length-of-stay (LOS), and improvement of smell scores in patients with COVID-19. # Methods We searched Embase, Web of Science, PubMed, Cochrane Library, and Scopus until Aug 2022. The Cochrane risk of bias tool was used to assess the quality of studies. We evaluated the effectiveness of ICS in COVID-19 patients through measures of mortality, LOS, alleviation of post-acute COVID-19 symptoms, time to sustained self-reported cure, and sense of smell (visual analog scale (VAS)). # Results Ten studies were included in the meta-analysis. Our study showed a significant decrease in the LOS in ICS patients over placebo (MD = -1.52, 95% CI \[-2.77 to -0.28\], *p-value* = 0.02). Patients treated with intranasal corticosteroids (INC) showed a significant improvement in VAS smell scores from week three to week four (MD =1.52, 95% CI \[0.27 to 2.78\], *p-value* = 0.02), and alleviation of COVID-related symptoms after 14 days (RR = 1.17, 95% CI \[1.09 to 1.26\], *p-value* \< 0.0001). No significant differences were detected in mortality (RR= 0.69, 95% CI \[0.36 to 1.35\], *p-value* = 0.28) and time to sustained self-reported cure (MD = -1.28, 95% CI \[-6.77 to 4.20\], *p-value* = 0.65). # Conclusion We concluded that the use of ICS decreased patient LOS and improved COVID-19-related symptoms. INC may have a role in improving the smell score. Therefore, using INC and ICS for two weeks or more may prove beneficial. Current data do not demonstrate an effect on mortality or time to sustained self-reported cure. However, the evidence is inconclusive, and more studies are needed for more precise data.
format Article
id doaj-art-8462e2fce9554d02b35d4ccac810844c
institution Kabale University
issn 2368-6820
language English
publishDate 2023-08-01
publisher Canadian Society of Respiratory Therapists
record_format Article
series Canadian Journal of Respiratory Therapy
spelling doaj-art-8462e2fce9554d02b35d4ccac810844c2025-02-11T20:30:50ZengCanadian Society of Respiratory TherapistsCanadian Journal of Respiratory Therapy2368-68202023-08-0159Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trialsYasra BadiMohamed HammadAbdelrahman G. TawfikMona Muhe Eldeen EshagMahmoud M. ElhadyKhaled Mohamed RagabAnas Zakarya NoureldenMohamed Hesham GamalAhmed Hashem Fathallah# Background More than six million people died due to COVID-19, and 10-15% of infected individuals suffer from post-covid syndrome. Corticosteroids are widely used in the management of severe COVID-19 and post-acute COVID-19 symptoms. This study synthesizes current evidence of the effectiveness of inhaled corticosteroids (ICS) on mortality, hospital length-of-stay (LOS), and improvement of smell scores in patients with COVID-19. # Methods We searched Embase, Web of Science, PubMed, Cochrane Library, and Scopus until Aug 2022. The Cochrane risk of bias tool was used to assess the quality of studies. We evaluated the effectiveness of ICS in COVID-19 patients through measures of mortality, LOS, alleviation of post-acute COVID-19 symptoms, time to sustained self-reported cure, and sense of smell (visual analog scale (VAS)). # Results Ten studies were included in the meta-analysis. Our study showed a significant decrease in the LOS in ICS patients over placebo (MD = -1.52, 95% CI \[-2.77 to -0.28\], *p-value* = 0.02). Patients treated with intranasal corticosteroids (INC) showed a significant improvement in VAS smell scores from week three to week four (MD =1.52, 95% CI \[0.27 to 2.78\], *p-value* = 0.02), and alleviation of COVID-related symptoms after 14 days (RR = 1.17, 95% CI \[1.09 to 1.26\], *p-value* \< 0.0001). No significant differences were detected in mortality (RR= 0.69, 95% CI \[0.36 to 1.35\], *p-value* = 0.28) and time to sustained self-reported cure (MD = -1.28, 95% CI \[-6.77 to 4.20\], *p-value* = 0.65). # Conclusion We concluded that the use of ICS decreased patient LOS and improved COVID-19-related symptoms. INC may have a role in improving the smell score. Therefore, using INC and ICS for two weeks or more may prove beneficial. Current data do not demonstrate an effect on mortality or time to sustained self-reported cure. However, the evidence is inconclusive, and more studies are needed for more precise data.https://doi.org/10.29390/001c.84260
spellingShingle Yasra Badi
Mohamed Hammad
Abdelrahman G. Tawfik
Mona Muhe Eldeen Eshag
Mahmoud M. Elhady
Khaled Mohamed Ragab
Anas Zakarya Nourelden
Mohamed Hesham Gamal
Ahmed Hashem Fathallah
Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
Canadian Journal of Respiratory Therapy
title Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
title_full Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
title_fullStr Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
title_full_unstemmed Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
title_short Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
title_sort inhaled corticosteroids effect on covid 19 patients a systematic review and meta analysis of randomized controlled trials
url https://doi.org/10.29390/001c.84260
work_keys_str_mv AT yasrabadi inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT mohamedhammad inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT abdelrahmangtawfik inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT monamuheeldeeneshag inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT mahmoudmelhady inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT khaledmohamedragab inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT anaszakaryanourelden inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT mohamedheshamgamal inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT ahmedhashemfathallah inhaledcorticosteroidseffectoncovid19patientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials